1. Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, University of California-San Francisco Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California, and Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts